Recombinant antibody production has become indispensable to the development of novel therapeutics. Chinese hamster ovary (CHO) cells have emerged as a leading platform for this purpose due to their potential to achieve high-level expression of complex protein molecules like antibodies. A variety of factors contribute to CHO cells' effectiveness in